Tag: Antimicrobial Resistance

PhagoMed Biopharma receives ‘Phönix 2018’ award in Austria

Vienna-based Biotech company PhagoMed Biopharma was awarded the Austrian Entrepreneurship Award 'Phönix 2018' in the category “Start-Up International”.

Scientists made a leap forward in the decoding of multi-resistant pathogens

Researchers at the University of Tübingen and the German Center for Infection Research (DZIF) have achieved a breakthrough in the decoding of multi-resistant pathogens. According to a study publish...

Roivant Sciences licenses a novel investigational biologic from iNtRON Bio

Roivant Sciences and iNtRON Biotechnology announced that they have entered into a licensing agreement for SAL200, a novel investigational biologic for the treatment of infectious diseases.

The round table on antimicrobial resistance was held in Moscow

Antimicrobial resistance
The round table on "Interaction between animal and human AMR. Myths and Challenges of Using Antibiotics in Food Producing Animals" was held at the British Ambassador's residence in Moscow.

Researchers developed an AI approach to identify antibiotic resistance genes

Researchers at the University of California San Diego have developed an approach that uses machine learning to identify and predict which genes make infectious bacteria resistant to antibiotics.

Sales of veterinary antimicrobials in Europe decreased by about 20%

A new report published by European Medicines Agency (EMA) shows that the overall sales of veterinary antimicrobials across Europe have decreased by more than 20% between 2011 and 2016.

Boston Pharmaceuticals licenses three anti-infective programs from Novartis

antimicrobial resistance
Novartis has entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel anti-infective drug candidates.

GARDP and Novartis to cooperate on enhancing generic antibiotics

microbiology plates
The Global Antibiotic Research & Development Partnership (GARDP) and Novartis are joining forces to accelerate the development and availability of generic antibiotic treatments for children.

Genentech antibiotic displays high activity against superbugs

antibiotic resistance
Recently published findings demonstrate that optimized arylomycin analogues could translate into new therapies to address the growing threat of multidrug-resistant Gram-negative infections.

Natural blue clay minerals are effective against major bacterial infections

Researchers at Arizona State University and Mayo Clinic have found that at least one type of blue clay may help fight disease-causing bacteria in wounds, including antibiotic-resistant bacteria.

Bioengineers discovered promising antibiotic candidates

Researchers from The Massachusetts Institute of Technology and the University of Naples Federico II found that fragments of the protein pepsinogen can kill bacteria such as Salmonella and E. coli.

British scientists launched new open-access database called AntibioticDB

microbiology plates
The new resource is the result of a collaboration between the University of Birmingham, the John Innes Centre and the British Society for Antimicrobial Chemotherapy.

UK government launches AMR research competition

Antimicrobial resistance
The Department of Health and Social Care (UK) is announcing the launch of a £10 million (approximately €11,3 million) research competition to fund innovations to tackle antimicrobial resistance in humans.

Boston College researchers made a step towards targeted antibiotics

The approach of Boston College scientists maps, ranks, and identifies where antibiotic sensitivity functions reside in the genome of strains of S. pneumoniae.

Four UK universities received research grants to fight AMR

antimicrobial resistance
Multimillion grants have been awarded to four UK universities to conduct interdisciplinary research into the biological, social, cultural and economic drivers behind the development of antimicrobial resistance (AMR).

Evotec and Sanofi join forces to fight infectious diseases

microbiology plates
Evotec signed a transaction agreement with Sanofi to integrate Sanofi’s infectious disease unit into its organisation. Evotec will also licence-in the majority of Sanofi’s infectious disease research portfolio and initiatives.